Aminoglycoside antibiotics belong to a stratum of antibiotics with amino sugars and amino globe alcohol structure. In the clinical trials, it is used for are treated for systemic illness caused by sensitive aerobic gram-negative bacilli
Aminoglycoside antibiotics get a leading position in Chinese market
In the 1960s to 1970s, it had been widely used In former years, because of widely clinical application of cephalosporins and quinolones antibiotics and its other serious ear renal toxicity, the application of aminoglycoside antibiotics gets some restrictions.
But because of the aminoglycoside antibiotics rail pseudomonas aeruginosa, klebsiella pneumonia coli and additional gram-negative bacilli PAE (postantibiotic effect) long, is inert used in the treatment of aerobic gram-negative bacilli docetaxel caused serious infections meningitis, respiratory tract, urinary tract, scrape and young tissue, gastrointestinal tract, burns, trauma and bone and joint infections, etc, in the antibiotics market, there is an irreplaceable role
Aminoglycoside antibiotics in clinical medicine in China in the far-reaching China’s newly revised health insurance directory, including the aminoglycoside antibiotics partly all clinical varieties Aminoglycoside antibiotics, accounting for all the antibiotics doorstep portion of around 3%, and the cephalosporins, penicillins, quinolones, and macrolide antibiotics constitute the paramount structure of the clinical use of antibiotics But compared with the strong momentum in the past two years, rising carbapenems, and endless gleam of new siring cephalosporins and quinolones irinotecan, aminoglycoside antibiotics obviously a stockpile less From the plane of the knot rate of the numeral of hospital medicine, aminoglycoside radical flat knob degree with the numeral of antibiotic medication.
Aminoglycoside antibiotics, the drugs ration the principal etimicin sell portion exceeds 80% in 2009. Etimicin is a new procreation semi-synthetic aminoglycoside antibiotic, has significant advantages as lofty efficiency, low toxicity, anti-drug-resistant, belonging to the antibiotics category of countries with independent academic property rights of a stratum of drugs
Currently, there are 34 production approvals for etimicin In China, there is impartial a hardly character of companies which are able to produce the etimicin Etimicin ranks second in allocation of aminoglycoside antibiotic medication The drug ration is 16.14 percent in 2008 with swift excrescence of drug character In contrast, the allowance of netilmicin decreased significantly from 24.22 percent in 2005l to 1.53 percent in 2009. Netilmicin has supplementary production enterprises in China The drug regulatory territory has awarded a amount of 169 creation approvals Source:http://wwwcospcn.com